This study aimed to evaluate cerebral magnetic resonance imaging (MRI) scans of children with prenatal drug exposure in a clinical context. A hospital-based cohort of 10-to 14-year-old children, prenatally exposed to alcohol, opioids, and polysubstances, and a group of sex-and age-matched controls were examined with cerebral MRI. Scans obtained from 34 exposed children and 40 controls were scored based on the presence and degree of pathology by an experienced pediatric neuroradiologist blinded to the participants' background. Overall visual detectable MRI pathology was found in 35% of the exposed children and 33% of the controls (odds ratio = 1.08; 95% confidence interval = 0.36-3.25). No specific imaging pattern following prenatal drug exposure was seen by the means of simple visual analysis of cerebral MRI scans. Although cerebral MRI is feasible, it is probably of limited value in the clinical assessment of children with prenatal drug exposure.
Introduction
Children exposed to substance abuse in utero have increased risk of unfavorable outcomes in the perinatal period, neonatal period, and long term. [1] [2] [3] There is growing evidence from advanced imaging studies that prenatal exposure to both alcohol and other drugs is associated with structural brain changes. 4, 5 Theories on how intrauterine drug exposure affects the developing brain can explain some of the unfavorable outcomes in this group of children. 6 After fetal alcohol syndrome (FAS) was first described by Smith and Jones in 1973, 7 the adverse effects of prenatal alcohol exposure have been well documented in the literature, describing teratogenic effects with congenital anomalies, growth restriction, and cognitive impairments. 1 Brain changes in children with prenatal alcohol exposure have been described in several imaging studies, with reduction of the overall brain size as the most consistent finding. 5, 8 Specific patterns of changes shown in advanced morphometric analyses have suggested certain structures like the basal ganglia, 9 corpus callosum, 10 and cerebellum 11 to be especially vulnerable to the adverse effect of alcohol. Several gross structural abnormalities, like agenesis or severe hypoplasia of the corpus callosum and atrophy of the cerebellum, have been reported in studies using qualitative analysis of magnetic resonance imaging (MRI) scans. [12] [13] [14] Children prenatally exposed to opioids, both from abuse (most often heroin) and from opioids given as part of opioid maintenance treatment (OMT), constitute a large group. 15, 16 However, literature on possible morphological brain changes in this group is so far very limited. 4 In a pilot study including 7 neonates prenatally exposed to buprenorphine, no major structural abnormalities were found. 17 Volumetric differences were shown in a controlbased study of 14 prenatally opioid and polysubstance exposed school-aged children. 18 In small samples of neonates prenatally exposed to buprenorphine/methadone both altered white matter characteristics compared to 19, 20 Reduced brain volumes are also reported in children prenatally exposed to amphetamines 21 and cocaine, 22 although the literature on these drugs is also limited compared to literature on prenatal alcohol exposure. For cocaine-exposed children, a variety of gross structural abnormalities including cortical infarcts were reported in early imaging studies. 4 However, no significant difference in the incidence of structural brain abnormalities between cocaine-exposed neonates and unexposed controls could be found in a more recent prospective, longitudinal study. 23 There has been little research evaluating brain structure in children with prenatal exposure to cannabis. One recent study reported changes in cortical thickness. 24 In summary, evidence supporting the association between prenatal exposure to different drugs of abuse and structural brain changes in children is accumulating. However, it is not clear whether cerebral MRI is useful in the clinical assessment of these children. In the present study, a hospital-based cohort of children prenatally exposed to alcohol, opioids, and polysubstances was examined with cerebral MRI. The aims were to investigate if cerebral pathology detectable on expert visual analysis is more common in this group compared to unexposed controls, and to explore if this analysis could reveal imaging patterns specific to prenatal drug exposure.
Material and Methods

Population
Children referred to the pediatric department at Haukeland University Hospital in Bergen, Norway, between 1997 and 2012, due to prenatal drug exposure, were invited to participate in a clinical follow-up study. The cohort included children hospitalized in the neonatal period due to maternal use of drugs in pregnancy, and children referred at a later age with symptoms of developmental impairments and a medical history of prenatal drug exposure. In the present study, children in the age range of 10 to 14 years were invited to undergo an MRI examination. Out of 70 eligible children, 43 (61%) consented to participate.
Drug Exposure
A child would only be included in the study if prenatal drug exposure could be confirmed, either in medical records (obstetric or pediatric) or by information from the mother herself. Children were categorized according to type of exposure as either alcohol exposed or opioid and polysubstance exposed. Children with fetal alcohol spectrum disorders (FASD), including FAS, were categorized as alcohol exposed. The group categorized as opioid and polysubstance exposed included both children exposed to street drugs and children of mothers in OMT. None of the children in the group exposed to opioids and polysubstances fulfilled the criteria for FASD.
Controls
For each drug-exposed child included, the first child of the same gender, with a birth weight above the 10th percentile (≥3000 g), born at Haukeland University Hospital on the same date, was invited to serve as a control. If they declined, the next child on the list was contacted. Forty-three controls without reports of prenatal substance abuse, according to questionnaires from their mothers, were recruited.
Magnetic Resonance Imaging, Data Acquisition
Examinations of the drug-exposed children and their controls were performed, without sedation, on a GE Signa Exite HD 3.0 Tesla (Milwaukee, WI) MRI scanner. The MRI protocol included a sagittal T1weighted 3D fast spoiled gradient recovery sequence (TI: 500, TE: out of phase, slice thickness 1.0 mm, and scan time 10:34 minutes) and an axial T2 weighted sequence (TE: 100, TR: 3000, slice thickness 0.8 mm, and scan time 5:40 minutes).
Evaluation of Magnetic Resonance Images
The scans were evaluated by an experienced pediatric neuroradiologist who was blinded to the background of the participants. Pathology was recorded in terms of (a) reduced volume of the cerebellum, (b) reduction in thickness of the corpus callosum, (c) pathology in the basal ganglia, (d) presence and extent of dilation of the lateral ventricles, and (e) presence of focal white matter pathology. Focal white matter pathology was based on identification of focal signal abnormalities or lesions in the white matter (typically asymmetric in distribution). Each parameter was scored as being either normal or as displaying mild or moderate/severe pathology. The assessment of each of these parameters was subjective. In addition to these 5 MRI parameters, other pathology was recorded, but not graded. Furthermore, an additional variable, termed any pathology, was interpreted as positive if the images showed MRI pathology in any of the 5 previously mentioned parameters.
Statistical Analyses
Descriptive statistics are reported using mean and standard deviation (SD). Paired t tests were used to compare means of drug exposed groups and matched controls. For group comparisons of MRI findings, any degree of pathology in each of the 5 MRI parameters (reduced volume of the cerebellum, thinning of the corpus callosum, pathology in the basal ganglia, dilatation of the lateral ventricles, the presence of focal white matter pathology) and any pathology were considered categorical variables. Logistic regression of pathology (not normal/normal) on drug exposure/control using generalized estimating equations to adjust for the matching was performed. This analysis was selected because it allows information from incomplete pairs to be included, unlike McNemar's test that would otherwise have been appropriate to test differences between matched groups. Risk estimations were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). All significance tests were 2-sided, and a significance level of 5% was used. Statistical analyses were performed in IBM SPSS Statistics Version 22.
Ethics
The project was approved by the Regional Ethics Committee for Medical Research in Western Norway (REK-Vest 2010/3301). Written consent was obtained from parents or foster parents and Child Welfare Services for all participants. Written consent was also obtained from all children above the age of 12 years, and oral consent was obtained from participants younger than 12 years.
Results
Study Population
Forty-three (43/70) prenatally drug-exposed children and 43 controls were examined with MRI. Two exposed children and 2 controls were not able to complete any of the planned MRI sequences. In addition, scans of 5 exposed children and 1 control were excluded from the analysis due to movement artifacts. Furthermore, scans of 2 exposed children were excluded due to dental braces distorting the images. Finally, 34/43 (79%) of the exposed children and 40/43 (93%) of the controls were included in the analysis. For 6 children in this final population (3 exposed children and 3 controls), only T1 weighted scans were obtained (obsoleting the T2 weighted sequence). There were 32 complete pairs of exposed children and controls matched 1:1 for sex and age. The MRI scan of the control was missing in 2 matched pairs. For 8 pairs there were missing MRI data for the exposed child.
Among the prenatally drug-exposed children included in the analysis, 12/34 (35%) were exposed to alcohol. The remaining 22/34 (65%) were exposed to opioids and polysubstances. Seven of these 22 children were born of mothers in OMT, and 15 were exposed to street drugs. For 16/22 exposure to opioids could be documented, either from opioids given as part of OMT or from abuse of heroin. Exposure to benzodiazepines, cannabis, and amphetamines were reported to a varying extent. With few exceptions (among children of mothers in OMT), exposure to more than one drug was reported. Descriptive statistics of the study population is shown in Table 1 . Age and sex distribution was similar in all groups. The alcoholexposed group had lower head circumference compared to controls (mean difference = 2.18 cm; 95% CI = 0.84, 3.51; P = .004). Head circumference in the subgroup exposed to opioids and polysubstances did not differ from controls (mean difference = 0.39 cm; 95% CI =: −0.83, 1.60; P = .52). Among the 27 nonparticipants in the present MRI study, 19 were included in other parts of the clinical follow-up. Type of drug exposure and intelligence quotient for these 19 children did not differ significantly from what was found in the drug-exposed group participating in the MRI study. Obtained for 28 drug-exposed children (9 alcohol exposed, 19 opioid and polysubstance exposed) and 38 controls. b Intelligence quotient in drug-exposed children assessed with Wechsler Intelligence Scale for Children-Fourth Edition. Controls were matched for sex and age. In 2 matched pairs there was no measurement for the control, and for 8 pairs there were missing values for the exposed child. b P value: From logistic regression of pathology (not normal/normal) on drug exposure/control using generalized estimating equations to adjust for the matching. 
MRI Findings
Pathology scores and group comparisons are given in Table 2 . Overall pathological findings categorized as any pathology were recorded in 35% of the drug-exposed children versus 33% of the controls (OR = 1.08; 95% CI = 0.36-3.25). No statistically significant group differences were found. Noteworthy reduced cerebellar volume was recorded in 3/12 alcohol-exposed children, but subgroups based on major drug exposure were too small for meaningful statistical analysis of group differences. Overall similar frequencies of pathology were found in all groups, with any pathology recorded in 33% of the alcohol-exposed children and 36% of the children exposed to opioids and polysubstances. No pathology in the basal ganglia was identified. Other pathology (not among the 5 major findings) was found in 3 participants: 1 small arachnoid cyst and 2 developmental venous anomalies. No pathological findings specific for any of the drugexposed groups could be identified. Pathology described as moderate/severe was limited to 1 drug-exposed participant. The rest of the pathological findings were categorized as mild.
Discussion
In the present hospital-based study, the frequency of cerebral MRI pathology did not differ between children with prenatal exposure to alcohol, opioids, and polysubstances and unexposed controls. The diagnostic approach from everyday clinical practice, including visual analysis of the MRI scans, did not reveal brain changes specific to prenatal drug exposure.
The literature is diverging when it comes to visual analysis of cerebral MRI scans of children prenatally exposed to alcohol. Brain anomalies in up to 100% alcohol-exposed children have been reported, 14 while other studies report structural abnormalities in less than 10%. 25, 26 As suggested by Clark et al, there seems to be a continuum of brain changes due to alcohol exposure, ranging from changes at a micro-level to gross structural anomalies. 25 Our findings could support brain changes in alcoholexposed children being mostly subtle and visible mainly on a micro-level. For children with prenatal alcohol exposure, lower total brain volumes should be expected based on existing literature. 5 No measurement of total brain volume was performed in our analysis, but head circumference, known to correlate well with brain volume at a given age, 27 was lower in our group of alcohol-exposed children. In accordance with our results, no association between pathology from visual analysis of cerebral MRI scans and prenatal exposure to opioids and polysubstances has been reported in other cross-sectional studies. 17, 18, 20 However, a link between maternal opioid use during pregnancy and neonatal stroke has been suggested in a case report. 28 Cerebellum seems to be one of the brain structures most vulnerable to the adverse effects of prenatal alcohol. 11, 12 Reduced volume of the cerebellum in 4/12 (25%) alcoholexposed children in our study could support this, even if groups are too small for meaningful statistical testing. Riikonen et al report cerebellar atrophy diagnosed by visual analysis in 3/11 (27%) children with FAS, 13 while
Autti-Ramo et al report hypoplasia of the vermis in 10/17 (59%) children with prenatal alcohol exposure. 12 None of these studies had a control/comparison group. Keeping in mind that visual analyses of MRI scans are subjective in nature, frequency of cerebellar atrophy in these reports should be interpreted with caution.
Frequency or grade of thinning of the corpus callosum was not higher in the drug-exposed group compared to controls in the present study. Agenesis, hypoplasia, and thinning of the corpus callosum are among the structural brain changes most often reported in imaging studies of children with prenatal alcohol exposure using qualitative analyses. 12, 14, 25 Lack of control groups in many of these early studies should be kept in mind when comparing with our results. Reduction of volume and variations in shape of the corpus callosum associated with prenatal alcohol exposure reported in studies using advanced computerized measurements 10 may represent mainly changes not detectable by simple visual inspection.
The basal ganglia seem to be especially vulnerable to the adverse effects of prenatal alcohol exposure. 5, 9 Volume reductions in these structures have also been shown in children prenatally exposed to opioids, amphetamines, and cocaine compared to controls using quantitative measures. 18, 21, 22 No gross pathology in the basal ganglia was found in our analysis, suggesting that possible drug-related changes are mainly subtle, not detectable on visual analysis.
Both mild ventricular dilatation and focal white matter pathology were seen in the present study, but there were no differences between the exposed group and the control group. These findings have earlier been shown to be common when MRI scans from healthy control children are assessed by visual analysis. 29, 30 When studying a hospital-based population, one might expect children with the most severe cognitive and behavioral problems to be selected. If these problems are related to structural brain changes due to prenatal drug exposure, one would expect such changes to be more frequent in a hospital-based population. A selective recruitment of the most impaired children could therefore not explain the lack of gross structural changes associated with prenatal drug exposure in our study. On the other hand, we do not know for certain if some of the most impaired children eligible to the study refused to participate, and thereby introduced a selection bias. Our sample size is small, especially when splitting into smaller subgroups based on type of drug exposure. Future studies in larger populations are therefore recommended to confirm our findings.
Like most studies of prenatally drug-exposed children, information in our study regarding drug exposure has some limitations. Due to heavy substance abuse, detailed information about type, timing, frequency, or amounts of drugs used during pregnancy was rarely available. However, if prenatal drug exposure could not be verified, children were not included. Most children were exposed to more than one drug. Although the exposed group in our study is heterogeneous regarding drug exposure, the results are clinical relevant, since polysubstance exposure and unspecified drug exposure is common in a clinical setting. 31 Using expert visual analysis of cerebral MRI scans instead of quantitative methods like computerized volumetric measurements is a limitation of our study. However, the aim of the study was to evaluate MRI scans in a clinical context. Although studies including morphometry and functional aspects are important to elucidate the adverse effects of prenatal drug exposure on the developing brain, simple visual analysis of MRI scans still represents the common method used in everyday clinical practice. The same expert evaluating all scans, and the fact that the expert was blinded to the participants' background, are important strengths of our study. Only one radiologist evaluating the scans may be considered a weakness, as substantial differences between observers evaluating MRI scans by visual analysis have been shown. 29 However, the observers' choice of threshold between normal and pathological may explain most of the differences shown in such studies. Group comparisons, like the present study, will not be influenced by such interobserver disagreements, as long as the threshold between normal and pathological is equal in all groups.
Conclusions
Brain changes associated with prenatal drug exposure were not seen by the means of simple visual analysis of cerebral MRI scans. No specific imaging pattern following prenatal drug exposure was found, as the exposed children and their controls shared the same MRI findings. Although evidence of associations between prenatal drug exposure and future brain changes is growing, most of these changes seem to be limited to subtle changes not detectable on simple visual analysis. Cerebral MRI is feasible, but probably of limited value in the clinical assessment of children with prenatal drug exposure.
